RCEL

AVITA Medical Inc

Add to Watchlist

Advanced Chart

5.170

-0.26(-4.788%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

5.850

Open

5.500

VWAP

5.20

Vol

434.71K

Mkt Cap

136.67M

Low

5.0327

Amount

2.26M

EV/EBITDA(TTM)

Total Shares

25.80M

152.31M

EV/OCF(TTM)

P/S(TTM)

1.88

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

31.97M

+73.17%

0.096

-121.67%

26.36M

+34.68%

-0.101

-83.7%

22.48M

+47.56%

-0.235

-60.99%

Estimates Revision

The market is revising Downward the revenue expectations for AVITA Medical, Inc. (RCEL) for FY2025, with the revenue forecasts being adjusted by -3.39% over the past three months. During the same period, the stock price has changed by -43.19%.

Revenue Estimates for FY2025

Revise Downward

-3.39%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+235.41%

In Past 3 Month

Stock Price

Go Down

-43.19%

In Past 3 Month

3 Analyst Rating

193.42% Upside

Wall Street analysts forecast RCEL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RCEL is 15.17 USD with a low forecast of 12.50 USD and a high forecast of 19.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

0 Hold

0 Sell

Strong Buy

193.42% Upside

Current: 5.170

Low

12.50

Averages

15.17

High

19.00

193.42% Upside

Current: 5.170

Low

12.50

Averages

15.17

High

19.00

TD Cowen

Buy

downgrade

$15

2025-05-09

Reason

TD Cowen

Price Target

$15

2025-05-09

downgrade

Buy

Reason

D. Boral Capital

Jason Kolbert

Strong Buy

Maintains

$22

2025-04-10

Reason

D. Boral Capital

Jason Kolbert

Price Target

$22

2025-04-10

Maintains

Strong Buy

Reason

D. Boral Capital

Jason Kolbert

Strong Buy

Maintains

$22

2025-04-04

Reason

D. Boral Capital

Jason Kolbert

Price Target

$22

2025-04-04

Maintains

Strong Buy

Reason

D. Boral Capital

Jason Kolbert

Strong Buy

Maintains

$22

2025-03-18

Reason

D. Boral Capital

Jason Kolbert

Price Target

$22

2025-03-18

Maintains

Strong Buy

Reason

D. Boral Capital

Jason Kolbert

Strong Buy

Maintains

$25 → $22

2025-02-20

Reason

D. Boral Capital

Jason Kolbert

Price Target

$25 → $22

2025-02-20

Maintains

Strong Buy

Reason

D. Boral Capital lowered the firm's price target on Avita Medical to $22 from $25 and keeps a Buy rating on the shares. The CFO of Avita informed D. Boral that the company has no plans to enter the chronic wounds market for the foreseeable future. As a result, the firm removed chronic wounds from its model and adjusted its acute wounds market share assumptions to align with the company's published guidance. With limited resources, Avita is prioritizing areas where its product attributes can have the greatest impact, the analyst tells investors in a research note.

D. Boral Capital

Jason Kolbert

Strong Buy

Maintains

$25

2025-02-14

Reason

D. Boral Capital

Jason Kolbert

Price Target

$25

2025-02-14

Maintains

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for AVITA Medical Inc (RCEL.O) is -11.64, compared to its 5-year average forward P/E of -5.70. For a more detailed relative valuation and DCF analysis to assess AVITA Medical Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-5.70

Current PE

-11.64

Overvalued PE

9.04

Undervalued PE

-20.43

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

14.07

Current EV/EBITDA

-8.53

Overvalued EV/EBITDA

105.80

Undervalued EV/EBITDA

-77.66

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

7.86

Current PS

1.39

Overvalued PS

13.98

Undervalued PS

1.75

Financials

Annual

Quarterly

FY2025Q1

YoY :

+66.73%

18.51M

Total Revenue

FY2025Q1

YoY :

-32.76%

-11.51M

Operating Profit

FY2025Q1

YoY :

-25.72%

-13.86M

Net Income after Tax

FY2025Q1

YoY :

-27.40%

-0.53

EPS - Diluted

FY2025Q1

YoY :

-52.16%

-10.53M

Free Cash Flow

FY2025Q1

YoY :

-0.84%

86.39

Gross Profit Margin - %

FY2025Q1

YoY :

-36.62%

-65.07

FCF Margin - %

FY2025Q1

YoY :

-55.45%

-74.86

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

212.3K

USD

Months

6-9

18.5K

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds areBuying! The buying amount has increased 534.61% over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

0.0

Volume

Months

6-9

0.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

212.3K

USD

Months

6-9

18.5K

USD

Months

0-12

0.0

USD

Months

RCEL News & Events

Events Timeline

2025-06-09 (ET)

2025-06-09

09:13:36

Avita Medical highlights data from real-world analysis of RECELL

2025-06-05 (ET)

2025-06-05

16:39:47

Avita Medical announces Cohealyx data published in Journal of Surgery

2025-05-08 (ET)

2025-05-08

16:21:54

Avita Medical reports Q1 EPS (53c), consensus (51c)

News

3.0

06-26Benzinga

Top 3 Health Care Stocks You'll Regret Missing This Quarter

4.0

06-10Benzinga

D. Boral Capital Maintains Buy on AVITA Medical, Maintains $19 Price Target

9.0

06-05Newsfilter

AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™

People Also Watch

KFS

Kingsway Financial Services Inc

14.320

USD

-1.58%

Empire Petroleum Corp

Chemung Financial Corp

Tevogen Bio Holdings Inc

Luminar Technologies Inc

FAQ

What is AVITA Medical Inc (RCEL) stock price today?

The current price of RCEL is 5.17 USD — it has decreased -4.79 % in the last trading day.

RCEL

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

RCEL News & Events

Events Timeline

News

People Also Watch

FAQ

What is AVITA Medical Inc (RCEL) stock price today?

What is AVITA Medical Inc (RCEL)'s business?

What is the price predicton of RCEL Stock?

What is AVITA Medical Inc (RCEL)'s revenue for the last quarter?

What is AVITA Medical Inc (RCEL)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for AVITA Medical Inc (RCEL)'s fundamentals?

How many employees does AVITA Medical Inc (RCEL). have?

What is AVITA Medical Inc (RCEL) market cap?